Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO CLINICAL BREAKTHROUGHS IN NEUROSCIENCES

March 2022

NEUROSCIENCES

RARE CENTRAL NERVOUS SYSTEM TUMORS: PROGRESS IN CLINICAL CARE AND RESEARCH

Featuring: Rimas V. Lukas, MD

Episode Summary

The Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is a nationally recognized leader in the fight against brain and spinal cord tumors. It offers patients individualized, compassionate care and the most advanced clinical trial and treatment options available. Rimas V. Lukas, MD, a member of Lurie Cancer Center and associate professor of Neurology in the Division of Neuro-oncology at Northwestern Medicine, joins the latest episode of the Better Edge podcast to discuss some of those options for patients with rare central nervous system (CNS) tumors. He talks about exciting research on the potential benefits of immunotherapy and the use of leading-edge technologies, including DNA methylation profiling, for diagnosis. Dr. Lukas also discusses some of the CNS specialized programs offered at Northwestern Medicine, such as the low-grade glioma program, Von Hippel-Lindau disease program and chordoma program.
Dr. Craig Horbinski headshot
Rimas V. Lukas, MD, is a member of Lurie Cancer Center and associate professor of Neurology in the Division of Neuro-oncology at Northwestern Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you on the care of your patients.
Call 844.344.6663
Find an NM Neurologist
FIND AN NM NEUROSURGEON
FIND AN NM NEURORADIOLOGIST

You May Also Like

scientific image

December 2021

NEUROSCIENCES
DNA Methylation Profiling in the Diagnosis of Brain Tumors
Physician scientists in a lab

July 2021

NEUROSCIENCES
Immunotherapy for Brain Tumors
Headshot of Dr. Priya Kumthekar

March 2021

NEUROSCIENCES
Northwestern Scientists Discover Potential Therapeutic Target for Glioblastoma

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties